Newborn Screening for Cystic Fibrosis, 2nd Edition
This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
Chairholder: Debra Freedenberg, MD, PhD, FFACMG
Date of Publication: December 19, 2019
Order Code PDF: NBS05Ed2E
ISBN Number: 978-1-68440-065-2
Order Code Print: NBS05Ed2
ISBN Number: 978-1-68440-064-5
NBS05 Additional Details
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.
This document was formerly sold under the code ILA35.